Randal D. Chase, Director at BIOJECT MEDICAL TECHNOLOGIES INC (BJCT), bought 10,000 shares at $1.39 ($14K) on 2007-06-14, disclosed to the SEC on 2007-06-18.
Open-market purchase of $14k BJCT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.33 | 5,084 | $7K | 49.7% |
| 2 | $1.39 | 4,916 | $7K | 50.3% |
| Total | $1.36 avg | 10,000 | $14K | 100% |
| Filing → |
| GOVX | BUY | 2020-09-29 | $83K | — | Filing → |
| GOVX | BUY | 2015-05-05 | $2K | — | Filing → |
| GOVX | BUY | 2015-04-20 | $5K | — | Filing → |